Urine proteome analysis reflects atherosclerotic disease in an ApoE -/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis

Molecular and Cellular Proteomics

Volumn 11, Issue 7, 2012, Pages

  Von Zur Muhlen, Constantin ^a   Schiffer, Eric ^b   Sackmann, Christine ^a,c   Zürbig, Petra ^b   Neudorfer, Irene ^a   Zirlik, Andreas ^a   Htun, Nay ^c   Ipho, Alexander ^d   Jänsch, Lothar ^d   Mischak, Harald ^b,e   Bode, Christoph ^a   Chen, Yung C ^c   Peter, Karlheinz ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d Helmholtz Institute   (Germany)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR; KIDNEY ANDROGEN REGULATED PROTEIN; POLYPEPTIDE; PROTEOME; UNCLASSIFIED DRUG; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIPID DIET; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; URINARY EXCRETION; URINE; WILD TYPE; ANIMAL; ATHEROSCLEROTIC PLAQUE; DISEASE COURSE; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; SEQUENCE ANALYSIS;

MURINAE; MUS;

ALPHA 1-ANTITRYPSIN; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COLLAGEN TYPE I; DIET, HIGH-FAT; DISEASE PROGRESSION; ELECTROPHORESIS, CAPILLARY; EPIDERMAL GROWTH FACTOR; HUMANS; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; PEPTIDES; PLAQUE, ATHEROSCLEROTIC; PROTEOME; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, PROTEIN;

EID: 84863786448     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.013847     Document Type: Article

References (53)

1. Murray, C. J., and Lopez, A. D. (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349, 1498-1504 (Pubitemid 27216360)
2. Mathers, C. D., and Loncar, D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3, e442
3. Gibbons, R. J., Balady, G. J., Bricker, J. T., Chaitman, B. R., Fletcher, G. F., Froelicher, V. F., Mark, D. B., McCallister, B. D., Mooss, A. N., O'Reilly, M. G., Winters, W. L., Gibbons, R. J., Antman, E. M., Alpert, J. S., Faxon, D. P., Fuster, V., Gregoratos, G., Hiratzka, L. F., Jacobs, A. K., Russell, R. O., and Smith, S. C. (2002) ACC/AHA 2002 guideline update for exercise testing: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J. Am. Coll. Cardiol. 40, 1531-1540 (Pubitemid 35192881)
4. Koenig, W., and Khuseyinova, N. (2007) Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler. Thromb. Vasc. Biol. 27, 15-26 (Pubitemid 46360377)
5. Peter, K., Nawroth, P., Conradt, C., Nordt, T., Weiss, T., Boehme, M., Wunsch, A., Allenberg, J., Kübler, W., and Bode, C. (1997) Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule- 1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 17, 505-512 (Pubitemid 27133140)
6. De Caterina, R., Basta, G., Lazzerini, G., Dell'Omo, G., Petrucci, R., Morale, M., Carmassi, F., and Pedrinelli, R. (1997) Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17, 2646-2654 (Pubitemid 28016004)
7. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695
8. Ridker, P. M. (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: Moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 49, 2129-2138
9. Morrow, D. A., and Braunwald, E. (2003) Future of biomarkers in acute coronary syndromes: Moving toward a multimarker strategy. Circulation 108, 250-252 (Pubitemid 36899010)
10. Zimmerli, L. U., Schiffer, E., Zürbig, P., Good, D. M., Kellmann, M., Mouls, L., Pitt, A. R., Coon, J. J., Schmieder, R. E., Peter, K. H., Mischak, H., Kolch, W., Delles, C., and Dominiczak, A. F. (2008) Urinary proteomic biomarkers in coronary artery disease. Mol. Cell. Proteomics 7, 290-298 (Pubitemid 351298443)
11. von Zur Muhlen, C., Schiffer, E., Zuerbig, P., Kellmann, M., Brasse, M., Meert, N., Vanholder, R. C., Dominiczak, A. F., Chen, Y. C., Mischak, H., Bode, C., and Peter, K. (2009) Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J. Proteome Res. 8, 335-345
12. Theodorescu, D., Fliser, D., Wittke, S., Mischak, H., Krebs, R., Walden, M., Ross, M., Eltze, E., Bettendorf, O., Wulfing, C., and Semjonow, A. (2005) Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 26, 2797-2808 (Pubitemid 41078989)
13. Theodorescu, D., and Mischak, H. (2007) Mass spectrometry based proteomics in urine biomarker discovery. World J. Urol. 25, 435-443
14. Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., and Maeda, N. (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 89, 4471-4475
15. Frommberger, M., Zürbig, P., Jantos, J., Krahn, T., Mischak, H., Pich, A., Just, I., Schmitt-Kopplin, P., and Schiffer, E. (2007) Peptidomic analysis of rat urine using capillary electrophoresis coupled to mass spectrometry. Proteomics Clin. Appl. 1, 650-660
16. Kolch, W., Neusüss, C., Pelzing, M., and Mischak, H. (2005) Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 24, 959-977 (Pubitemid 41641706)
17. Theodorescu, D., Wittke, S., Ross, M. M., Walden, M., Conaway, M., Just, I., Mischak, H., and Frierson, H. F. (2006) Discovery and validation of new protein biomarkers for urothelial cancer: A prospective analysis. Lancet Oncol. 7, 230-240 (Pubitemid 43286453)
18. Neuhoff, N., Kaiser, T., Wittke, S., Krebs, R., Pitt, A., Burchard, A., Sundmacher, A., Schlegelberger, B., Kolch, W., and Mischak, H. (2004) Mass spectrometry for the detection of differentially expressed proteins: A comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Mass Spectrom. Rev. 18, 149-156 (Pubitemid 38160349)
19. Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., and Metzger, J. (2009) Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J. Proteome Res. 8, 268-281
20. Good, D. M., Wenger, C. D., McAlister, G. C., Bai, D. L., Hunt, D. F., and Coon, J. J. (2009) Post-acquisition ETD spectral processing for increased peptide identifications. J. Am. Soc. Mass Spectrom. 20, 1435-1440
21. Good, D. M., Wenger, C. D., and Coon, J. J. (2010) The effect of interfering ions on search algorithm performance for electron-transfer dissociation data. Proteomics 10, 164-167
22. Zürbig, P., Renfrow, M. B., Schiffer, E., Novak, J., Walden, M., Wittke, S., Just, I., Pelzing, M., Neusüss, C., Theodorescu, D., Root, K. E., Ross, M. M., and Mischak, H. (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27, 2111-2125 (Pubitemid 43942113)
23. DeLeo, J. (1993) Receiver Operating Characteristics Laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty. Proceedings of the Second International Symposium on Uncertainty Modeling and Analysis, April 25, 1993. IEEE Computer Society Press, College Park, MD
24. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. Royal Stat. Soc. B 57, 125-133
25. Wittke, S., Fliser, D., Haubitz, M., Bartel, S., Krebs, R., Hausadel, F., Hillmann, M., Golovko, I., Koester, P., Haller, H., Kaiser, T., Mischak, H., and Weissinger, E. M. (2003) Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J. Chromatogr. A 1013, 173-181 (Pubitemid 37297584)
26. Yang, Z. R. (2004) Biological applications of support vector machines. Brief Bioinform. 5, 328-338
27. Girolami, M., Mischak, H., and Krebs, R. (2006) Analysis of complex, multidimensional datasets. Drug Discov. Today 3, 12-19
28. Weissinger, E. M., Wittke, S., Kaiser, T., Haller, H., Bartel, S., Krebs, R., Golovko, I., Rupprecht, H. D., Haubitz, M., Hecker, H., Mischak, H., and Fliser, D. (2004) Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 65, 2426-2434 (Pubitemid 38670029)
29. Delles, C., Schiffer, E., von zur Muhlen, C., Peter, K., Rossing, P., Parving, H. H., Dymott, J. A., Neisius, U., Zimmerli, L. U., Snell-Bergeon, J. K., Maahs, D. M., Schmieder, R. E., Mischak, H., and Dominiczak, A. F. (2010) Urinary proteomic diagnosis of coronary artery disease: Identification and clinical validation in 623 individuals. J. Hypertens. 28, 2316-2322
30. Decramer, S., Wittke, S., Mischak, H., Zürbig, P., Walden, M., Bouissou, F., Bascands, J. L., and Schanstra, J. P. (2006) Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 12, 398-400
31. Good, D. M., Zürbig, P., Argilés, A., Bauer, H. W., Behrens, G., Coon, J. J., Dakna, M., Decramer, S., Delles, C., Dominiczak, A. F., Ehrich, J. H., Eitner, F., Fliser, D., Frommberger, M., Ganser, A., Girolami, M. A., Golovko, I., Gwinner, W., Haubitz, M., Herget-Rosenthal, S., Jankowski, J., Jahn, H., Jerums, G., Julian, B. A., Kellmann, M., Kliem, V., Kolch, W., Krolewski, A. S., Luppi, M., Massy, Z., Melter, M., Neusüss, C., Novak, J., Peter, K., Rossing, K., Rupprecht, H., Schanstra, J. P., Schiffer, E., Stolzenburg, J. U., Tarnow, L., Theodorescu, D., Thongboonkerd, V., Vanholder, R., Weissinger, E. M., Mischak, H., and Schmitt-Kopplin, P. (2010) Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol. Cell. Proteomics 9, 2424-2437
32. Weissinger, E. M., Schiffer, E., Hertenstein, B., Ferrara, J. L., Holler, E., Stadler, M., Kolb, H. J., Zander, A., Zürbig, P., Kellmann, M., and Ganser, A. (2007) Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 109, 5511-5519 (Pubitemid 46890577)
33. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J. H., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D., Jankowski, J., Julian, B. A., Kolch, W., Massy, Z. A., Neusuess, C., Novak, J., Peter, K., Rossing, K., Schanstra, J., Semmes, O. J., Theodorescu, D., Thongboonkerd, V., Weissinger, E. M., Van Eyk, J. E., and Yamamoto, T. (2007) Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 1, 148-156
34. Mischak, H., Kolch, W., Aivaliotis, M., Bouyssié, D., Court, M., Dihazi, H., Dihazi, G. H., Franke, J., Garin, J., Gonzalez de Peredo, A., Iphöfer, A., Jänsch, L., Lacroix, C., Makridakis, M., Masselon, C., Metzger, J., Monsarrat, B., Mrug, M., Norling, M., Novak, J., Pich, A., Pitt, A., Bongcam- Rudloff, E., Siwy, J., Suzuki, H., Thongboonkerd, V., Wang, L. S., Zoidakis, J., Zürbig, P., Schanstra, J. P., and Vlahou, A. (2010) Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin. Appl. 4, 464-478
35. Talmud, P. J., Martin, S., Steiner, G., Flavell, D. M., Whitehouse, D. B., Nagl, S., Jackson, R., Taskinen, M. R., Frick, M. H., Nieminen, M. S., Kesäniemi, Y. A., Pasternack, A., Humphries, S. E., and Syvänne, M. (2003) Progression of atherosclerosis is associated with variation in the α1-antitrypsin gene. Arterioscler. Thromb. Vasc. Biol. 23, 644-649 (Pubitemid 36438078)
36. Dichtl, W., Moraga, F., Ares, M. P., Crisby, M., Nilsson, J., Lindgren, S., and Janciauskiene, S. (2000) The carboxyl-terminal fragment of α1-antitrypsin is present in atherosclerotic plaques and regulates inflammatory transcription factors in primary human monocytes. Mol. Cell. Biol. Res Commun 4, 50-61 (Pubitemid 32060004)
37. Janciauskiene, S., Moraga, F., and Lindgren, S. (2001) C-terminal fragment of α1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor. Atherosclerosis 158, 41-51 (Pubitemid 32735466)
38. Bironaite, D., Lindgren, S., and Janciauskiene, S. (2001) Fibrillogenic C-terminal fragment of α-1-antitrypsin activates human monocytes via oxidative mechanisms. Cell Tissue Res. 305, 87-98 (Pubitemid 32681871)
39. Nakamura, K., Sasaki, T., Cheng, X. W., Iguchi, A., Sato, K., and Kuzuya, M. (2009) Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation. Atherosclerosis 206, 355-361
40. Lamb, D. J., Modjtahedi, H., Plant, N. J., and Ferns, G. A. (2004) EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis 176, 21-26 (Pubitemid 39078640)
41. Dreux, A. C., Lamb, D. J., Modjtahedi, H., and Ferns, G. A. (2006) The epidermal growth factor receptors and their family of ligands: Their putative role in atherogenesis. Atherosclerosis 186, 38-53
42. Tang, E. H., Shimizu, K., Christen, T., Rocha, V. Z., Shvartz, E., Tesmenitsky, Y., Sukhova, G., Shi, G. P., and Libby, P. (2011) Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions. Cardiovasc Res. 89, 234-243
43. Tornavaca, O., Pascual, G., Barreiro, M. L., Grande, M. T., Carretero, A., Riera, M., Garcia-Arumi, E., Bardaji, B., González- Núñez, M., Montero, M. A., López-Novoa, J. M., and Meseguer, A. (2009) Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress. Circulation 119, 1908-1917
44. Hui, X., Zhu, W., Wang, Y., Lam, K. S., Zhang, J., Wu, D., Kraegen, E. W., Li, Y., and Xu, A. (2009) Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice. J. Biol. Chem. 284, 14050-14057
45. Schlieper, G., Westenfeld, R., Brandenburg, V., and Ketteler, M. (2007) Inhibitors of calcification in blood and urine. Semin. Dial. 20, 113-121
46. Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., and Nilsson, J. (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 103, 926-933 (Pubitemid 32183796)
47. Kim, H. C., Greenland, P., Rossouw, J. E., Manson, J. E., Cochrane, B. B., Lasser, N. L., Limacher, M. C., Lloyd-Jones, D. M., Margolis, K. L., and Robinson, J. G. (2010) Multimarker prediction of coronary heart disease risk: The Women's Health Initiative. J. Am. Coll. Cardiol. 55, 2080-2091
48. Schnabel, R. B., Schulz, A., Messow, C. M., Lubos, E., Wild, P. S., Zeller, T., Sinning, C. R., Rupprecht, H. J., Bickel, C., Peetz, D., Cambien, F., Kempf, T., Wollert, K. C., Benjamin, E. J., Lackner, K. J., Münzel, T. F., Tiret, L., Vasan, R. S., and Blankenberg, S. (2010) Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur. Heart J. 31, 3024-3031
49. Good, D. M., Wirtala, M., McAlister, G. C., and Coon, J. J. (2007) Performance characteristics of electron transfer dissociation mass spectrometry. Mol. Cell. Proteomics 6, 1942-1951 (Pubitemid 350213868)
50. Good, D. M., and Coon, J. J. (2006) Advancing proteomics with ion/ion chemistry. BioTechniques 40, 783-789 (Pubitemid 46534919)
51. Gebauer, P., Beckers, J. L., and Bocek, P. (2002) Theory of system zones in capillary zone electrophoresis. Electrophoresis 23, 1779-1785 (Pubitemid 34752850)
52. Li, J., Wang, C., Kelly, J. F., Harrison, D. J., and Thibault, P. (2000) Rapid and sensitive separation of trace level protein digests using microfabricated devices coupled to a quadrupole-time-of-flight mass spectrometer. Electrophoresis 21, 198-210 (Pubitemid 30032714)
53. Li, J., LeRiche, T., Tremblay, T. L., Wang, C., Bonneil, E., Harrison, D. J., and Thibault, P. (2002) Application of microfluidic devices to proteomics research: Identification of trace-level protein digests and affinity capture of target peptides. Mol. Cell. Proteomics 1, 157-168